Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-12

FDA Approved: ENTECAVIR — Original Application (AvKARE)

View source ↗

Summary

FDA approved AvKARE's original application for entecavir (generic) for chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENTECAVIR (ENTECAVIR)

Snippet

ORIG AP for ENTECAVIR (ENTECAVIR)